Hussein Arkhagha

Hussein Arkhagha is a declared insider of Hikma Pharmaceuticals PLC, with filings sourced from RNS (LSE). Over a trading history stretching from 12 March 2024 to 1 June 2026, the count stands at 13 filings.

The open-market record is one-sided, with 6 purchases worth €86k and not one sale. The totals do not cover 5 filings with an undisclosed amount. Unlike grants, an open-market purchase is paid for by the insider, at the market price. The rest of the record consists of 7 share grants. Since January 2026: 3 purchases and no sales on the market.

Of 6 purchases, 3 formed part of a group of insiders buying within 30 days of each other. When several insiders buy within a few weeks of each other, analysts speak of a cluster purchase. For 5 purchases whose 90-day window has closed, the share price was higher on day 90 than the day after publication in 80% of cases, with a median move of +5.6%. They describe history only and say nothing certain about the share price ahead.

The latest filing, published on 5 June 2026, reports an open-market purchase in Hikma Pharmaceuticals PLC. Typically, a trade is published a median of 2 days after it takes place. The regulation allows three business days to notify a trade (UK MAR). These figures are compiled from regulatory filings published by RNS (LSE). They describe what insiders did and are not a recommendation.